LANXESS AG
LANXESS AG (LNXSF) Financial Performance & Income Statement Overview
Review LANXESS AG (LNXSF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
LANXESS AG (LNXSF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for LANXESS AG LNXSF financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.60B | $1.48B | $1.60B | $1.68B |
| Cost of Revenue | $1.28B | $1.18B | $1.25B | $1.31B |
| Gross Profit | $322.00M | $305.00M | $349.00M | $364.00M |
| Gross Profit Ratio | $0.20 | $0.21 | $0.22 | $0.22 |
| R&D Expenses | $29.00M | $22.00M | $27.00M | $27.00M |
| SG&A Expenses | $290.00M | $275.00M | $289.00M | $293.00M |
| Operating Expenses | $345.00M | $328.00M | $325.00M | $336.00M |
| Total Costs & Expenses | $1.62B | $1.51B | $1.57B | $1.65B |
| Interest Income | $2.00M | $2.00M | $1.00M | $1.00M |
| Interest Expense | $12.00M | $11.00M | -$13.00M | $12.00M |
| Depreciation & Amortization | $135.00M | $146.00M | $139.00M | $141.00M |
| EBITDA | $86.00M | $118.00M | $154.00M | $141.00M |
| EBITDA Ratio | $0.05 | $0.08 | $0.10 | $0.08 |
| Operating Income | -$23.00M | -$23.00M | $24.00M | $28.00M |
| Operating Income Ratio | -$0.01 | -$0.02 | $0.02 | $0.02 |
| Other Income/Expenses (Net) | -$38.00M | -$45.00M | -$22.00M | -$40.00M |
| Income Before Tax | -$61.00M | -$68.00M | $2.00M | -$12.00M |
| Income Before Tax Ratio | -$0.04 | -$0.05 | $0.001 | -$0.007 |
| Income Tax Expense | -$4.00M | -$4.00M | $0.00 | $4.00M |
| Net Income | -$57.00M | -$64.00M | $1.00M | -$16.00M |
| Net Income Ratio | -$0.04 | -$0.04 | $0.001 | -$0.010 |
| EPS | -$0.66 | -$0.74 | $0.01 | -$0.19 |
| Diluted EPS | -$0.66 | -$0.74 | $0.01 | -$0.19 |
| Weighted Avg Shares Outstanding | $86.35M | $86.35M | $86.35M | $86.35M |
| Weighted Avg Shares Outstanding (Diluted) | $86.35M | $86.35M | $86.35M | $86.35M |
Over the past four quarters, LANXESS AG demonstrated steady revenue growth, increasing from $1.68B in Q2 2024 to $1.60B in Q1 2025. Operating income reached -$23.00M in Q1 2025, maintaining a consistent -1% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $86.00M, reflecting operational efficiency. Net income rose to -$57.00M, with EPS at -$0.66. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan